Filing Details

Accession Number:
0001193805-24-000245
Form Type:
4
Zero Holdings:
No
Publication Time:
2024-02-16 14:37:50
Reporting Period:
2024-02-16
Accepted Time:
2024-02-16 14:37:50
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1374690 Larimar Therapeutics Inc. LRMR () DE
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1009258 Deerfield Management Company, L.p. (Series C) 345 Park Avenue South, 12Th Floor
New York NY 10010
Yes No Yes Yes
1010823 L.p. Mgmt Deerfield 345 Park Avenue South, 12Th Floor
New York NY 10010
Yes No Yes Yes
1301041 Deerfield Partners, L.p. 345 Park Avenue South, 12Th Floor
New York NY 10010
Yes No Yes Yes
1352546 E James Flynn 345 Park Avenue South, 12Th Floor
New York NY 10010
Yes No Yes Yes
1603333 Deerfield Private Design Fund Iii, L.p. 345 Park Avenue South, 12Th Floor
New York NY 10010
Yes No Yes Yes
1610540 Deerfield Mgmt Iii, L.p. 345 Park Avenue South, 12Th Floor
New York NY 10010
Yes No Yes Yes
1646981 Deerfield Healthcare Innovations Fund, L.p. 345 Park Avenue South, 12Th Floor
New York NY 10010
Yes No Yes Yes
1665736 Deerfield Mgmt Hif, L.p. 345 Park Avenue South, 12Th Floor
New York NY 10010
Yes No Yes Yes
1680307 Deerfield Private Design Fund Iv, L.p. 345 Park Avenue South, 12Th Floor
New York NY 10010
Yes No Yes Yes
1713467 Deerfield Mgmt Iv, L.p. 345 Park Avenue South, 12Th Floor
New York NY 10010
Yes No Yes Yes
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2024-02-16 1,430,206 $8.74 6,151,389 No 4 P Indirect Through Deerfield Private Design Fund III, L.P.
Common Stock Acquisiton 2024-02-16 1,430,206 $8.74 6,151,406 No 4 P Indirect Through Deerfield Private Design Fund IV, L.P.
Common Stock Acquisiton 2024-02-16 1,430,205 $8.74 4,207,982 No 4 P Indirect Through Deerfield Partners, L.P.
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Indirect Through Deerfield Private Design Fund III, L.P.
No 4 P Indirect Through Deerfield Private Design Fund IV, L.P.
No 4 P Indirect Through Deerfield Partners, L.P.
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 4,721,197 Indirect Through Deerfield Healthcare Innovations Fund, L.P.
Footnotes
  1. This Form 4 is being filed by the undersigned as well as the entities listed on the Joint Filer Information Statement attached as an exhibit hereto (the "Reporting Persons"). Deerfield Mgmt III, L.P. is the general partner of Deerfield Private Design Fund III, L.P. ("Fund III"). Deerfield Mgmt IV, L.P. is the general partner of Deerfield Private Design Fund IV, L.P. ("Fund IV"). Deerfield Mgmt HIF, L.P. is the general partner of Deerfield Healthcare Innovations Fund, L.P. ("Deerfield HIF"). Deerfield Mgmt, L.P. is the general partner of Deerfield Partners, L.P. ("Deerfield Partners"). Deerfield Management Company, L.P. is the investment manager of Deerfield Partners, L.P., Fund III, Fund IV and Deerfield HIF (collectively, the "Funds"). James E. Flynn is the sole member of the general partner of each of Deerfield Mgmt III, L.P., Deerfield Mgmt IV, L.P., Deerfield Mgmt HIF, L.P., Deerfield Mgmt, L.P. and Deerfield Management Company, L.P.
  2. In accordance with Instruction 4 (b)(iv) to Form 4, the entire amount of the Issuer's securities held by the Funds is reported herein. For purposes of Section 16 of the Securities Exchange Act of 1934, as amended, each Reporting Person disclaims beneficial ownership of any such securities, except to the extent of his/its indirect pecuniary interest therein, if any, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of such securities for purposes of Section 16 or otherwise.